SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-034239
Filing Date
2024-03-14
Accepted
2024-03-14 07:45:22
Documents
52
Period of Report
2024-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248573d2_8k.htm   iXBRL 8-K 31271
2 EXHIBIT 99.1 tm248573d2_ex99-1.htm EX-99.1 83826
3 EXHIBIT 99.2 tm248573d2_ex99-2.htm EX-99.2 54842
7 GRAPHIC tm248573d2_ex99-2img001.jpg GRAPHIC 137684
8 GRAPHIC tm248573d2_ex99-2img002.jpg GRAPHIC 339984
9 GRAPHIC tm248573d2_ex99-2img003.jpg GRAPHIC 225245
10 GRAPHIC tm248573d2_ex99-2img004.jpg GRAPHIC 83275
11 GRAPHIC tm248573d2_ex99-2img005.jpg GRAPHIC 146552
12 GRAPHIC tm248573d2_ex99-2img006.jpg GRAPHIC 143374
13 GRAPHIC tm248573d2_ex99-2img007.jpg GRAPHIC 144007
14 GRAPHIC tm248573d2_ex99-2img008.jpg GRAPHIC 136290
15 GRAPHIC tm248573d2_ex99-2img009.jpg GRAPHIC 144391
16 GRAPHIC tm248573d2_ex99-2img010.jpg GRAPHIC 79378
17 GRAPHIC tm248573d2_ex99-2img011.jpg GRAPHIC 170446
18 GRAPHIC tm248573d2_ex99-2img012.jpg GRAPHIC 85195
19 GRAPHIC tm248573d2_ex99-2img013.jpg GRAPHIC 125452
20 GRAPHIC tm248573d2_ex99-2img014.jpg GRAPHIC 170383
21 GRAPHIC tm248573d2_ex99-2img015.jpg GRAPHIC 183580
22 GRAPHIC tm248573d2_ex99-2img016.jpg GRAPHIC 143499
23 GRAPHIC tm248573d2_ex99-2img017.jpg GRAPHIC 137931
24 GRAPHIC tm248573d2_ex99-2img018.jpg GRAPHIC 142187
25 GRAPHIC tm248573d2_ex99-2img019.jpg GRAPHIC 148443
26 GRAPHIC tm248573d2_ex99-2img020.jpg GRAPHIC 202637
27 GRAPHIC tm248573d2_ex99-2img021.jpg GRAPHIC 158167
28 GRAPHIC tm248573d2_ex99-2img022.jpg GRAPHIC 132448
29 GRAPHIC tm248573d2_ex99-2img023.jpg GRAPHIC 191122
30 GRAPHIC tm248573d2_ex99-2img024.jpg GRAPHIC 191352
31 GRAPHIC tm248573d2_ex99-2img025.jpg GRAPHIC 157961
32 GRAPHIC tm248573d2_ex99-2img026.jpg GRAPHIC 198984
33 GRAPHIC tm248573d2_ex99-2img027.jpg GRAPHIC 193202
34 GRAPHIC tm248573d2_ex99-2img028.jpg GRAPHIC 210829
35 GRAPHIC tm248573d2_ex99-2img029.jpg GRAPHIC 138636
36 GRAPHIC tm248573d2_ex99-2img030.jpg GRAPHIC 211760
37 GRAPHIC tm248573d2_ex99-2img031.jpg GRAPHIC 84003
38 GRAPHIC tm248573d2_ex99-2img032.jpg GRAPHIC 141170
39 GRAPHIC tm248573d2_ex99-2img033.jpg GRAPHIC 133650
40 GRAPHIC tm248573d2_ex99-2img034.jpg GRAPHIC 146061
41 GRAPHIC tm248573d2_ex99-2img035.jpg GRAPHIC 225400
42 GRAPHIC tm248573d2_ex99-1img001.jpg GRAPHIC 4860
  Complete submission text file 0001104659-24-034239.txt   8104163

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20240314.xsd EX-101.SCH 3018
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20240314_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20240314_pre.xml EX-101.PRE 22361
53 EXTRACTED XBRL INSTANCE DOCUMENT tm248573d2_8k_htm.xml XML 3740
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 24747949
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)